CLINICAL_TRIALS
trial_result
· 2012-10-22
Clinical Trial Update: Safety and PK Study of MP-424 to Treat Chronic Hepatitis C [Phase 1]
Summary
A Phase 1 safety and pharmacokinetics study of MP-424 for chronic hepatitis C has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2012-10-22